Pharmacy Compounded Sterile Preparation (CSP) VISN 15

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
36C25526R0023
Agency
Veterans Integrated Service Network 15 Veterans Health Administration, Department of Veterans Affairs
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
Q517 Pharmacy Services
Place of performance
Leavenworth, Kansas 66048, United States
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 (VISN 15) seeks a firm fixed-price, requirements-based IDIQ contract for pharmacy compounded sterile preparation services, including all medications, diluents, fluids, IV tubing, closed system drug transfer devices, and related compounding and administration supplies. The VA requires the contractor to aseptically compound hazardous and non-hazardous intravenous products in accordance with federal, state, and local laws, as well as USP 797, 800, and 795 standards, with FDA 503A compliance mandatory. Key contract requirements include next-day delivery by 9:00 AM CST for orders submitted by 2:00 PM CST, provision of segregated shipment and labeling for hazardous versus non-hazardous compounds, monthly viability results and certification reports, and annual updates to the VHA Pharmacy Benefits Management Assessment Guide for Compounded Sterile Preparations. Evaluation will be conducted using three primary criteria: technical capability, past performance, and price, with technical capability and past performance weighted more heavily than price. Critical deadlines include March 20, 2026, at 1:00 PM CST for submission of technical questions and April 7, 2026, at 1:00 PM CST for proposal submission, with all inquiries and responses directed to maria.owen2@va.gov.

This is an unrestricted acquisition with no set-aside designations, and no current incumbent contractor is identified in the solicitation materials. The estimated annual requirements total approximately 11,430 units of pharmaceutical products and 32,039 units of ancillary supplies across seven VA medical facilities, with the St. Louis facility representing the largest volume at approximately 85% of total drug requirements. The contract will run for five annual ordering periods from June 1, 2026, through May 31, 2031, representing a potential five-year engagement. Pricing is all-inclusive with no additional charges permitted for weekend deliveries or other services. Performance of work will occur primarily at the Leavenworth, Kansas location, though the contractor will serve 11 VA medical centers across Kansas, Missouri, and Illinois, including Columbia, Kansas City, Leavenworth, Topeka, Wichita, St. Louis (two locations), Poplar Bluff, Cape Girardeau, Marion, and Evansville. The small business size standard under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) is 1,300 employees.

Notice text

The VA Heartland Health Care Network (VISN 15) requires a VISN-wide contingency IDIQ Requirements contract for all medications, diluents, fluids, IV Tubing, closed system drug transfer devices and any other compounding and administration supplies items deemed necessary for the provision of hazardous and non-hazardous compounded intravenous products.  (Attachment D. 1) The quantities reflected in Attachment D.1 is estimated annual requirements provided for pricing and planning purposes. These figures do not represent guaranteed purchase commitments. Actual quantities ordered under this VISN-wide contingency Requirements contract will vary based on patient-specific needs and operational requirements throughout the contract term. The government reserves the right to order more or fewer quantities than estimated. All sterile products will be aseptically compounded based on patient specific orders, in accordance with federal, state and local laws and any regulatory or accrediting bodies.  Additionally, the vendor shall provide all deliveries and handling of materials and supplies to ensure appropriate storage conditions are maintained during shipment, to include segregated shipment and labeling for hazardous versus non-hazardous sterile compounds.  Pricing in B.2 Price/Cost Schedule is all inclusive.

Contractor shall provide and update the “VHA Pharmacy Benefits Management (PBM) Assessment Guide for Compounded Sterile Preparations within VAMCs and Outsourced Compounding Pharmacies” at time of solicitation response and annually thereafter (See Attachment D. 2 VHA PBM)

Attachments

Files attached to this notice, newest first
File Type Posted
D.3 Past Peformance Contacts.docx DOCX document
D.1 Summary of Services.xlsx XLSX spreadsheet
D.2 VHA PBM.pdf PDF
36C25526R0023_VISN15 Compounding Services_final.pdf PDF

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
Q517--36C25526D0052 | Pharmacy Compounded Sterile Preparation (CSP) Contingency | Optum Infusion Services 308, LLC | VISN 15 | 09/01/2026 - 08/31/2031 | Award Award Notice
Pharmacy Compounded Sterile Preparation (CSP) VISN 15 This notice · Latest solicitation Solicitation
Q517--Pharmacy Compounded Sterile Preparation (CSP) Contingency | VISN 15 | Mission Critical | Original Pre-Solicitation

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity